RE:RE:RE:RE:RE:UofA study results outCiao,
This is an excellent question, one that the company has had to deal with for many years now.
I have to think that the retail investor re Ceapro is limited until the company can actually detail more in layman terms what this really means from a potential or ultimate revenue generation and relate a product to those revenues.
Yes, many retail investors will latch on but I have to think that the instituional side of the street or a partner will be the main cog in the "market" wheel.